Arcus Biosciences received Orphan Drug Designation from the U.S. FDA on July 10, 2025.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Arcus Biosciences received Orphan Drug Designation from the U.S. FDA on July 10, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Arcus Biosciences
biopharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireArcus Biosciences’ Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer PRISM-1, the ongoing registrational, Phase 3 study evaluating quemliclustat plus chemotherapy as a first-line t